• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: COOK IRELAND LTD RESONANCE STENT SET; FAD STENT, URETERAL

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

COOK IRELAND LTD RESONANCE STENT SET; FAD STENT, URETERAL Back to Search Results
Catalog Number UNKNOWN
Device Problem Complete Blockage (1094)
Patient Problem Obstruction/Occlusion (2422)
Event Date 09/08/2021
Event Type  Injury  
Manufacturer Narrative
Investigation is still pending, a follow up mdr will be submitted to include the investigation conclusions.
 
Event Description
Kobayashi et al 2021, ¿patency period of a metallic ureteral stent and its determinants in patients with malignant ureteral obstruction: a prospective review¿.We performed stent placement in 21 patients, bilaterally in six and unilaterally in 15 patients.One month after placement of the polymer ureteral stent, we replaced it with a metallic ureteral stent.We inserted the 8.3-fr metallic ureteral stent introducer over the guide-wire under fluoroscopic guidance and advanced it to the ureteropelvic junction.We confirmed that the proximal curl of the stent was located in the renal pelvis and the distal curl was located in the bladder.The length of the metallic ureteral stent was determined according to the length of the ureter.We did not perform balloon dilation of ureteral strictures.Obstruction occurred in five patients, of whom two easily underwent stent exchange.The patient in case 5 experienced disease progression and stent obstruction after chemotherapy withdrawal.Although she resumed chemotherapy after stent exchange, she was eventually diagnosed as having progressive disease and stent obstruction occurred thereafter.One patient did not require stent exchange due to best supportive care.The other two patients were in poor general condition and did not require additional treatment.The extracted metallic ureteral stents did not display apparent encrustation macroscopically.Obstruction occurred in five patients, of whom two easily underwent stent exchange.
 
Manufacturer Narrative
Device evaluation the unknown devices of unknown lot number involved in this complaint were not available for evaluation.With the information provided, a document based investigation was conducted.Lab evaluation ¿ n/a.Document review: as the rpn and lot number of the complaint stents are unknown, a review of the relevant manufacturing records cannot be conducted.However, prior to distribution rms devices are subjected to a visual inspection and functional checks to ensure device integrity.These inspections and functional checks are outlined in internal procedures in place at cirl.It should be noted that the instructions for use (ifu0020) lists diminished urine drainage/ stent occlusion as a known potential adverse event associated with rms procedures.Image review ¿ n/a.Root cause review: a definitive root cause could not be determined as the circumstances of use cannot be replicated in the laboratory.A possible root cause could be attributed to patient pre-existing conditions.As per the ifu, diminished urine drainage/ stent occlusion is listed as a known potential adverse event associated with rms procedures.Summary: the complaint is confirmed based on customer testimony.According to the initial reporter, two patients easily underwent stent exchange.One patient experienced disease progression and stent obstruction after chemotherapy withdrawal.Although she resumed chemotherapy after stent exchange, she was eventually diagnosed as having progressive disease and stent obstruction occurred thereafter.One patient did not require stent exchange due to best supportive care.The other two patients were in poor general condition and did not require additional treatment.Complaints of this nature will continue to be monitored for potential emerging trends.
 
Event Description
Supplemental report is being submitted due to the completion of the investigation.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
RESONANCE STENT SET
Type of Device
FAD STENT, URETERAL
Manufacturer (Section D)
COOK IRELAND LTD
o halloran road
limerick
Manufacturer (Section G)
COOK IRELAND
holstein campus kiel
arnold- keller str- 3
limerick
Manufacturer Contact
sinead o'leary
holstein campus kiel
arnold- keller str- 3
limerick 
MDR Report Key12769089
MDR Text Key283976658
Report Number3001845648-2021-00791
Device Sequence Number1
Product Code FAD
Combination Product (y/n)N
PMA/PMN Number
K063742
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Literature
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 07/11/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Catalogue NumberUNKNOWN
Device Lot NumberUNKNOWN
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Was the Report Sent to FDA? No
Distributor Facility Aware Date09/08/2021
Event Location Hospital
Initial Date Manufacturer Received 10/11/2021
Initial Date FDA Received11/08/2021
Supplement Dates Manufacturer Received10/11/2021
Supplement Dates FDA Received08/09/2022
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient SexFemale
-
-